Skip to main content
. 2011 Oct 26;11:463. doi: 10.1186/1471-2407-11-463

Table 2.

Clinicopathological features of patients with VSCC

n percentage
T stage
1 22 37.3%
2 24 40.7%
3 9 15.3%
4 0 0.0%
Not available 4 6.8%
Lymphe node metasases
None 24 40.7%
Unilateral 14 23.7%
Bilateral 6 10.2%
Not available 15 25.4%
Distant metastases
No 28 47.5%
Yes 1 1.7%
Not available 30 50.8%
FIGO
I 16 27.1%
II 12 20.3%
III 13 22.1%
IV 5 9.5%
Not available 13 22.0%
Tumor differentiation
Well 13 22.0%
Moderate 30 50.8%
Poor 16 27.1%